Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06511479 · ClinicalTrials.gov registry record · NA

Jackson Heart Study Women's Hypertension Study

A NA study of Hypertension, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT06511479 is a NA study of Hypertension that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 300 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06511479, a NA study of Hypertension, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

High blood pressure is a powerful risk factor for heart disease. Black women are more likely to have high blood pressure than white women or Hispanic women. Even when they are aware they have high blood pressure, many people struggle to keep their blood pressure controlled. Research shows a connection between life stress and high blood pressure and heart disease outcomes. Mindfulness training programs can help people regulate their emotions and cope with stress. Research shows that mindfulness programs can also lower blood pressure. This study will compare two programs: MIND-BP, a Zoom-based mindfulness training group; and BOOST, a Zoom-based support group. The aims of the study are to test if the MIND-BP program leads to greater reductions in blood pressure, stress and depressive symptoms than the BOOST program in Black women with high blood pressure who are participating in the Jackson Heart Study. The primary outcome measure is 6-month change in systolic blood pressure. The secondary outcome measures are 6-month changes in perceived stress and depressive symptoms.

Conditions Studied

Interventions

  • BEHAVIORAL MIND-BP
  • BEHAVIORAL BOOST

Study Locations (1)

Mississippi

  • University of Mississippi Medical Center - Jackson

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2024-11-18
Est. Completion 2027-05-30
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT06511479

The ClinicalTrials.gov registry entry for NCT06511479 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which MIND-BP is the first listed.

NCT06511479 reports 1 study location spanning 1 distinct geographic area - top geographies include Mississippi.

Frequently Asked Questions

What is clinical trial NCT06511479 about?

NCT06511479 is a clinical study titled "Jackson Heart Study Women's Hypertension Study". High blood pressure is a powerful risk factor for heart disease. Black women are more likely to have high blood pressure than white women or Hispanic women. Even when they are aware they have high blood pressure, many people struggle to keep their blood pressure controlled. Research shows a connecti...

What is the current status of trial NCT06511479?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-11-18. Estimated completion is 2027-05-30.

What conditions does trial NCT06511479 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT06511479?

The interventions under investigation include: MIND-BP (BEHAVIORAL), BOOST (BEHAVIORAL).

Who is sponsoring clinical trial NCT06511479?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06511479 being conducted?

This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.